Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1992 Apr;65(4):503–508. doi: 10.1038/bjc.1992.104

DNA fragmentation, dATP pool elevation and potentiation of antifolate cytotoxicity in L1210 cells by hypoxanthine.

J B Kwok 1, M H Tattersall 1
PMCID: PMC1977543  PMID: 1562458

Abstract

Exogenous purines (greater than or equal to 10(-5)M) can modulate the cytotoxicity of methotrexate (MTX) in cultured cells, protecting cells at low MTX concentrations (less than or equal to 8 x 10(-8) M) and markedly potentiating its effect at higher concentrations. The ability of hypoxanthine (HX) to modulate the effects of two antifolates-ICI 198583 (an inhibitor of thymidylate synthetase) and piritrexim (PTX, a lipophilic inhibitor of DHFR)-was investigated using cultured mouse leukaemic cells, L1210. HX (10(-4) M) was found to potentiate only the cytotoxicity of DHFR inhibitors (MTS and PTX), increasing cell kill by 20-70 fold to the level achieved by an equivalent concentration (10(-5) M) of ICI 198583 alone. Agarose gel electrophoresis of DNA extracted from cells exposed to antifolates for 24 h demonstrated that the chromatin was cleaved into multimers of 200 base pairs. This pattern of DNA cleavage indicates cell death via apoptosis. The degree of DNA fragmentation was found to be closely linked to cytotoxicity. DNA fragmentation increased from 50% in cells treated with 10(-5) M MTX or PTX to 70% when HX was added with the drugs, a level achieved by 10(-5)M ICI 198583 alone. HX potentiation of cytotoxicity was correlated with a substantial increase in dATP in conjunction with low dTTP pools. The specific potentiation of DHFR inhibitors by HX may be due to their inhibition of purine synthesis with a concurrent rise in PRPP levels. Addition of HX with MTX substantially raised intracellular purine levels via the salvage pathway as indicated by ribonucleotide pool measurements. ICI 198583, on the other hand, stimulated de novo purine synthesis with or without added HX. Treatment with MTX plus HX or ICI 198583 (with or without HX) caused a reduction of dTTP pools to 8% of untreated control and excess dATP accumulation. The subsequent elevation (to 300% of control) of the dATP pool may provide a signal for endonucleolytic fragmentation of DNA and subsequent cell death.

Full text

PDF
503

Images in this article

505Figure 3
on p.505

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borsa J., Whitmore G. F. Cell killing studies on the mode of action of methotrexate on L-cells in vitro. Cancer Res. 1969 Apr;29(4):737–744. [PubMed] [Google Scholar]
  2. Cadman E., Heimer R., Davis L. Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: explanation for drug synergism. Science. 1979 Sep 14;205(4411):1135–1137. doi: 10.1126/science.472732. [DOI] [PubMed] [Google Scholar]
  3. Duch D. S., Edelstein M. P., Bowers S. W., Nichol C. A. Biochemical and chemotherapeutic studies on 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine (BW 301U), a novel lipid-soluble inhibitor of dihydrofolate reductase. Cancer Res. 1982 Oct;42(10):3987–3994. [PubMed] [Google Scholar]
  4. Fairchild C. R., Maybaum J., Straw J. A. Enhanced cytotoxicity with methotrexate in conjunction with hypoxanthine in L1210 cells in culture. Cancer Chemother Pharmacol. 1988;22(1):26–32. doi: 10.1007/BF00254176. [DOI] [PubMed] [Google Scholar]
  5. Galivan J., Nimec Z., Rhee M., Boschelli D., Oronsky A. L., Kerwar S. S. Antifolate drug interactions: enhancement of growth inhibition due to the antipurine 5,10-dideazatetrahydrofolic acid by the lipophilic dihydrofolate reductase inhibitors metoprine and trimetrexate. Cancer Res. 1988 May 1;48(9):2421–2425. [PubMed] [Google Scholar]
  6. Goulian M., Bleile B., Tseng B. Y. Methotrexate-induced misincorporation of uracil into DNA. Proc Natl Acad Sci U S A. 1980 Apr;77(4):1956–1960. doi: 10.1073/pnas.77.4.1956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kaufmann S. H. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res. 1989 Nov 1;49(21):5870–5878. [PubMed] [Google Scholar]
  8. Kemp A. J., Lyons S. D., Christopherson R. I. Effects of acivicin and dichloroallyl lawsone upon pyrimidine biosynthesis in mouse L1210 leukemia cells. J Biol Chem. 1986 Nov 15;261(32):14891–14895. [PubMed] [Google Scholar]
  9. Kyprianou N., Isaacs J. T. "Thymineless" death in androgen-independent prostatic cancer cells. Biochem Biophys Res Commun. 1989 Nov 30;165(1):73–81. doi: 10.1016/0006-291x(89)91035-8. [DOI] [PubMed] [Google Scholar]
  10. Lorico A., Toffoli G., Boiocchi M., Erba E., Broggini M., Rappa G., D'Incalci M. Accumulation of DNA strand breaks in cells exposed to methotrexate or N10-propargyl-5,8-dideazafolic acid. Cancer Res. 1988 Apr 15;48(8):2036–2041. [PubMed] [Google Scholar]
  11. Lyons S. D., Christopherson R. I. Effects of brequinar and ciprofloxacin on de novo nucleotide biosynthesis in mouse L1210 leukemia. Biochem Int. 1990 Dec;22(6):939–949. [PubMed] [Google Scholar]
  12. Mann G. J., Fox R. M. Deoxyadenosine triphosphate as a mediator of deoxyguanosine toxicity in cultured T lymphoblasts. J Clin Invest. 1986 Nov;78(5):1261–1269. doi: 10.1172/JCI112710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Meuth M. The molecular basis of mutations induced by deoxyribonucleoside triphosphate pool imbalances in mammalian cells. Exp Cell Res. 1989 Apr;181(2):305–316. doi: 10.1016/0014-4827(89)90090-6. [DOI] [PubMed] [Google Scholar]
  14. Sant M. E., Poiner A., Harsanyi M. C., Lyons S. D., Christopherson R. I. Chromatographic analysis of purine precursors in mouse L1210 leukemia. Anal Biochem. 1989 Oct;182(1):121–128. doi: 10.1016/0003-2697(89)90728-8. [DOI] [PubMed] [Google Scholar]
  15. Sellins K. S., Cohen J. J. Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. J Immunol. 1987 Nov 15;139(10):3199–3206. [PubMed] [Google Scholar]
  16. Sen S., Erba E., D'Incalci M. Synchronisation of cancer cell lines of human origin using methotrexate. Cytometry. 1990;11(5):595–602. doi: 10.1002/cyto.990110506. [DOI] [PubMed] [Google Scholar]
  17. Seto S., Carrera C. J., Wasson D. B., Carson D. A. Inhibition of DNA repair by deoxyadenosine in resting human lymphocytes. J Immunol. 1986 Apr 15;136(8):2839–2843. [PubMed] [Google Scholar]
  18. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol. 1981 Apr;126(4):1614–1619. [PubMed] [Google Scholar]
  19. Taylor I. W., Slowiaczek P., Francis P. R., Tattersall M. H. Purine modulation of methotrexate cytotoxicity in mammalian cell lines. Cancer Res. 1982 Dec;42(12):5159–5164. [PubMed] [Google Scholar]
  20. Taylor I. W., Tattersall M. H. Methotrexate cytotoxicity in cultured human leukemic cells studied by flow cytometry. Cancer Res. 1981 Apr;41(4):1549–1558. [PubMed] [Google Scholar]
  21. Wyllie A. H., Morris R. G., Smith A. L., Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol. 1984 Jan;142(1):67–77. doi: 10.1002/path.1711420112. [DOI] [PubMed] [Google Scholar]
  22. Yoshioka A., Tanaka S., Hiraoka O., Koyama Y., Hirota Y., Ayusawa D., Seno T., Garrett C., Wataya Y. Deoxyribonucleoside triphosphate imbalance. 5-Fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death. J Biol Chem. 1987 Jun 15;262(17):8235–8241. [PubMed] [Google Scholar]
  23. Yoshioka A., Tanaka S., Hiraoka O., Koyama Y., Hirota Y., Wataya Y. Deoxyribonucleoside-triphosphate imbalance death: deoxyadenosine-induced dNTP imbalance and DNA double strand breaks in mouse FM3A cells and the mechanism of cell death. Biochem Biophys Res Commun. 1987 Jul 15;146(1):258–264. doi: 10.1016/0006-291x(87)90719-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES